Kalaris Therapeutics, Inc. (KLRS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-04

Kalaris Therapeutics, Inc. (KLRS) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-04. 3 Form 8-K material event filings were reported by KLRS in the last 90 days. InsiderAlpha tracks every KLRS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Kalaris Therapeutics, Inc. (KLRS)

SEC CIK0001754068

90-Day SEC Filing Activity

Form 4 filings (90d)8
Form 8-K filings (90d)3
Latest Form 4 filing2026-06-04

Recent KLRS Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
AKKARAJU SRINIVASInsiderJ — Other acquisition / disposition4.5K$0.00—SEC
AKKARAJU SRINIVASInsiderJ — Other acquisition / disposition14.9K$0.00—SEC
AKKARAJU SRINIVASInsiderJ — Other acquisition / disposition66.9K$0.00—SEC
AKKARAJU SRINIVASInsiderP — Open-market purchase244.3K$4.83$1.18MSEC
Hagen Brett RChief Accounting OfficerS — Open-market sale1.9K$6.72$13KSEC
AKKARAJU SRINIVASInsiderP — Open-market purchase479.8K$10.42$5.00MSEC
Miller EdwardGeneral CounselG — Bona-fide gift57.5K$0.00—SEC
Miller EdwardGeneral CounselG — Bona-fide gift57.5K$0.00—SEC
Sinha VikasSee RemarksS — Open-market sale3.2K$0.55$2KSEC
Miller EdwardGeneral CounselS — Open-market sale432$0.55$237SEC
Hagen Brett RChief Accounting OfficerS — Open-market sale554$0.55$304SEC
Brainard DianaChief Executive OfficerS — Open-market sale8.7K$0.55$5KSEC
Hagen Brett RChief Accounting OfficerS — Open-market sale1.7K$0.86$1KSEC
Brainard DianaChief Executive OfficerS — Open-market sale10.6K$0.86$9KSEC
Miller EdwardGeneral CounselS — Open-market sale2.3K$0.86$2KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Kalaris Therapeutics, Inc. (KLRS). Updated in real time as new filings are submitted to the SEC.

Most-Active KLRS Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
AKKARAJU SRINIVAS5$1.18M
Hallal David1—
PATTERSON LEONE D1—
ADAMIS ANTHONY P1—
Dybbs Michael1—

Recent KLRS Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in KLRS insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

KLRS Insider Trading — FAQ

What is the latest insider trade for KLRS?
Kalaris Therapeutics, Inc. (KLRS) had 8 insider filings in the last 90 days, with the most recent on 2026-06-04. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying KLRS stock?
0 insider purchases of KLRS were filed in the last 90 days.
How many insiders are selling KLRS stock?
0 insider sales of KLRS were filed in the last 90 days.
Where can I see KLRS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every KLRS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live KLRS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.